Winton Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-15,569
| Closed | -$392K | – | 1446 |
|
|
2020
Q4 | $392K | Sell |
15,569
-6,468
| -29% | -$163K | 0.03% | 912 |
|
|
2020
Q3 | $459K | Sell |
22,037
-129,129
| -85% | -$2.69M | 0.01% | 1144 |
|
|
2020
Q2 | $3.59M | Sell |
151,166
-212,034
| -58% | -$5.04M | 0.09% | 369 |
|
|
2020
Q1 | $6.53M | Buy |
363,200
+20,849
| +6% | +$375K | 0.17% | 158 |
|
|
2019
Q4 | $8.12M | Sell |
342,351
-181,074
| -35% | -$4.3M | 0.11% | 305 |
|
|
2019
Q3 | $14.4M | Buy |
523,425
+149,559
| +40% | +$4.11M | 0.17% | 168 |
|
|
2019
Q2 | $12.4M | Buy |
373,866
+70,566
| +23% | +$2.33M | 0.24% | 153 |
|
|
2019
Q1 | $10.6M | Buy |
303,300
+16,515
| +6% | +$579K | 0.21% | 184 |
|
|
2018
Q4 | $9.53M | Buy |
286,785
+263,097
| +1,111% | +$8.74M | 0.21% | 214 |
|
|
2018
Q3 | $1.19M | Buy |
23,688
+14,717
| +164% | +$741K | 0.03% | 373 |
|
|
2018
Q2 | $537K | Sell |
8,971
-6,424
| -42% | -$385K | 0.01% | 622 |
|
|
2018
Q1 | $705K | Buy |
+15,395
| New | +$705K | 0.02% | 635 |
|